Continued methylphenidate or atomoxetine use may be safe, but additional studies are needed.
Lauren Biscaldi is the Managing Editor of Drug Topics, a publication focused on retail, community, and health systems pharmacy. With a background in pharmacy journalism, Lauren covers a wide range of topics including drug approvals, clinical updates, healthcare policies, and patient care. Her work has been featured in publications such as Patient Care, Psychiatric Times, and Dermatology Times.